Skip to main content
Clinical Trials/CTIS2022-502292-39-00
CTIS2022-502292-39-00
Recruiting
Phase 1

Does adding patient-controlled sedation with propofol during repair of obstetric perineal lacerations grade I and II improve patient experiences - a randomized control trial - PROP(ofol)

Region Oestergoetland0 sites80 target enrollmentDecember 16, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Obstetric perineal lacerations
Sponsor
Region Oestergoetland
Enrollment
80
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 16, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Region Oestergoetland

Eligibility Criteria

Inclusion Criteria

  • Adult patient (\=18 years), Planned examination and repair of perineal laceration grades I or II, The patient has after receiving verbal and written information about the study given her signed informed consent to participate

Exclusion Criteria

  • BMI \> 35 (during first visit at the maternity care centre), Preeclampsia or hypertensive disease, Postpartum haemorrhage \> 1000 ml, Known/suspected allergy or contraindication to any medication within the study, Functional disability in both hands which affect the possibility to operate the PCS device, Cognitive impairment, unwillingness or language difficulties resulting in difficulty to understand the meaning of participation in the study or to operate the PCS device, Perineal laceration grade III\-IV, Deviation from department guidlines regarding preopartive fasting

Outcomes

Primary Outcomes

Not specified

Similar Trials